Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 2, 2002, Pages 285-289

  Liu, Zhi Su ^a   Jiang, Cong Qing ^a   Qian, Qun ^a   Sun, Quan ^a   Fan, Li Fang ^a   Ai, Zhong Li ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Acute pancreatitis; APACHE II; Trypsinogen activation peptide

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN ACTIVATION PEPTIDE;

ACUTE PANCREATITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; PREDICTION; PROTEIN URINE LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; URINALYSIS;

ACUTE DISEASE; AMYLASES; APACHE; HUMANS; OLIGOPEPTIDES; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0038544464     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Buchler MW, Uhl W, Andren-sandberg A. CAPAP in acute pancreatitis: just another marker of real progress? Gut 1998;42:8-10.
2. Tenner S, Fernabdez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105-110.
3. Health DI, Cruickshank A, Gudgeon AM, et al. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995;10:347-353.
4. Perejaslov A, Clooklin S. Trypsinogen activation peptides assay in the prediction of severity of acute pancreatitis. Eur Surg Res 1999;31 (Suppl 1):202-205.
5. British Society of Gastroenterology. United Kingdom Guidelines for the management of acute pancreatitis. Gut 1998;42(Suppl 2):1-3.
6. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the international symposium an acute pancreatitis. Arch Surg 1993; 128:586-590.
7. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II , clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-1264.
8. Funakoshi A, Yamada Y, Migita Y, et al. Simultaneous determination of pancreatic phospholipase A2 and prophospholipase A2 in various pancreatic disease. Dig Dis Sci 1993;38:502-506.
9. Viedma JA, Perez-Mateo M, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994;35:822-827.
10. Domingguez-Munoz JE, Carballo F, Carcia MJ, et al. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Results of a prospective multicenter study. Dig Dis Sci 1993;38:507-513.
11. Hartwig W, Werner J, Jimenez RE, et al. Trypsin and activation of circulating trypsinogen contributes to pancreatitis-associated lung injury (PALI). Am J Physiol 1999;277:1008-1016.
12. Hartwig W, Jimenez RE, Werner J, et al. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology 1999;117:717-725.
13. Lundberg AH, Eubanks III JW, Henry J, et al. Trypsin stimulates production of cytokines from peritoneal macrophages in vitro and in vivo. Pancreas 2000;21:41-51.
14. Hurley PR, Cook A, Jehanli A, et al. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988;111:195-203.
15. Schmidt J, Fernandez-del Castillo C, Rattner DW, et al. Trypsinogen activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology 1992; 103: 1009-1016.
16. Foitzik T, Lewandrowski KB, Fernandez-del Castillo C, et al. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis. Surgery 1994;115:698-702.
17. Merriam LT, Wilcockson D, Samuel I. Ligation-induced acute pancreatitis increases pancreatic and circulating trypsinogen activation peptide. J Surg Res 1996;60:417-421.
18. Wang YX, Naruse S, Kitagawa M, et al. Urinary excretion trypsinogen activation peptide (TAP) in taurocholated-induced pancreatitis in rats. Pancreas 2001;22:24-27.
19. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.